Vernalis appoints new CEO and CFO
This article was originally published in Scrip
Vernalishas appointed Ian Garland chief executive officer, effective December, and David Mackney chief financial officer, effective February 2009. From May 2007 until September 2008, Mr Garland was CEO of Acambis. He has also served as CFO of Arrow Therapeutics, and as president and chief operating officer of Celltech Pharmaceuticals. From February 2008 to date, Mr Mackney has served as interim CFO at Acambis, working with Mr Garland to secure the US biodefence contract and the secondary financing. Before this he was CFO for a private equity-backed technology company.